On October 22, 2013, Thomas F. Deuel, who previously informed Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) that he will not stand ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE